Target intelligence / Profile preview

Hepatic leukemia factor pseudogene 1 (HLFP1)

Target: HLFP1
Molecular classification: Other (Pseudogene)

Overview

Hepatic leukemia factor pseudogene 1 (HLFP1) is a noncoding DNA sequence homologous to the hepatic leukemia factor gene but incapable of producing a functional protein[5]. Pseudogenes are generally classified as “junk DNA,” though research has revealed that a subset may play regulatory roles through their noncoding RNAs; for HLFP1, no function or disease association has been reported in the scientific literature[2]. HLFP1 is best classified strictly as a pseudogene rather than a functional molecular target and should not be used as a drug target designation. If additional functional data emerges—for example, evidence of regulatory noncoding RNA activity—a revision may be warranted, but none exists in current resources[2][5].

Other names: Hepatic leukemia factor pseudogene 1HLFP1

Biological functions

No specific biological function has been established for HLFP1. Generally, pseudogenes may contribute to genetic regulation via noncoding RNA mechanisms, such as acting as microRNA decoys or sources of siRNAs; however, such functions are not reported specifically for HLFP1.

Disease associations

Other. HLFP1 itself has no documented disease association. Some pseudogenes are implicated in cancer and other conditions, but there is no evidence for HLFP1.

Beyond the preview

Go deeper on Hepatic leukemia factor pseudogene 1 (HLFP1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hepatic leukemia factor pseudogene 1 (HLFP1).

Explore the full profile